EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Multizentrische StudieRandomisierte kontrollierte Studie

Geographic Variation in Diagnostic Performance of Amsel Criteria and Nugent Score for Vaginal Dysbiosis Defined by 16S rRNA Gene Sequencing

Meilin Zhu, Andile Mtshali, Gugulethu Mzobe, Nzuzo Magini, Nireshni Mitchev, Anam Khan iD, Briah Cooley Demidkina, Meena Murthy, Lara Lewis iD, Jiawu Xu iD, Johnathan Shih iD, Joseph Elsherbini und 11 weitere

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag399 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Meilin Zhu und 22 weiteren Autor:innen. Beteiligte Einrichtung: Ragon Institute of Mass General, Harvard and MIT, Cambridge Massachusetts, USA. Hauptthemen laut MEDLINE: Dysbiosis, RNA, Ribosomal, 16S, Vagina, Vaginosis, Bacterial. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vaginal dysbiosis characterized by low abundance of vaginal lactobacilli and increased bacterial community diversity, is implicated in multiple adverse health outcomes and is an emerging target for preventive interventions, including live biotherapeutic products. The most common clinical presentation of vaginal dysbiosis is bacterial vaginosis (BV), but at least half of people are asymptomatic.

Methods

We compared identification of BV by Nugent score and Amsel criteria for screening specimens from a Phase 1b randomized trial of a live biotherapeutic product conducted at 2 sites (CAPRISA, South Africa; MGH, USA), as well as a single follow-up visit from enrolled participants. Using 16S rRNA gene sequencing-based categorization of community state type (CST) as the reference and multinomial mixed-effects logistic models, we evaluated the association of Amsel BV and Nugent BV with CST IV (including subtypes IV-A and IV-B) and tested for site-specific effects.

Results

Amsel BV was significantly associated with CST IV-A and IV-B; however, the strength of association was significantly diminished at CAPRISA compared with MGH, pointing to site-specific assessment differences or underlying biological variation. Nugent BV yielded stronger associations with CST IV-A, and IV-B and showed no evidence of a site-specific interaction, indicating consistent performance across sites.

Conclusions

These findings indicate that diagnostic performance for vaginal dysbiosis varies by framework: Amsel criteria are more susceptible to geographical site effects, whereas Nugent score demonstrates stronger and more site-agnostic associations. For clinical studies targeting vaginal dysbiosis, Nugent scoring and/or sequencing-based approaches should be prioritized for vaginal dysbiosis endpoint definition and stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisRNA, Ribosomal, 16SVaginaVaginosis, BacterialAdultFemaleHumansYoung AdultLactobacillusMicrobiotaSequence Analysis, DNASouth Africa

Stichwörter der Autor:innen

Amsel criteriaNugent scorebacterial vaginosisvaginal dysbiosisvaginal microbiome

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Ragon Institute of Mass General, Harvard and MIT, Cambridge Massachusetts, USA.
  • Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
  • Department of Medical Microbiology, School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Louvain Institute of Data Analysis and Modeling (LIDAM), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
  • Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.

ORCID-Profile: Anam Khan, Lara Lewis, Jiawu Xu, Johnathan Shih, Jo-Ann S Passmore, Anna-Ursula Happel, Douglas S Kwon, Caroline M Mitchell

Förderung

  • Gates Foundation

Zitieren

APA

Zhu, M., Mtshali, A., Mzobe, G., Magini, N., Mitchev, N., Khan, A., Demidkina, B. C., Murthy, M., Lewis, L., Xu, J., Shih, J., Elsherbini, J., Kama, A., Mafunda, N. A., Chetty, C., Vermeren, L., Passmore, J. S., Happel, A. U., Kwon, D. S., …, & Mitchell, C. M. (2026). Geographic Variation in Diagnostic Performance of Amsel Criteria and Nugent Score for Vaginal Dysbiosis Defined by 16S rRNA Gene Sequencing. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag399

Vancouver

Zhu M, Mtshali A, Mzobe G, Magini N, Mitchev N, Khan A, et al. Geographic Variation in Diagnostic Performance of Amsel Criteria and Nugent Score for Vaginal Dysbiosis Defined by 16S rRNA Gene Sequencing. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag399

BibTeX
@article{Zhu2026,
  author = {Zhu, Meilin and Mtshali, Andile and Mzobe, Gugulethu and Magini, Nzuzo and Mitchev, Nireshni and Khan, Anam and Demidkina, Briah Cooley and Murthy, Meena and Lewis, Lara and Xu, Jiawu and Shih, Johnathan and Elsherbini, Joseph and Kama, Asavela and Mafunda, Nomfuneko A and Chetty, Callin and Vermeren, Laura and Passmore, Jo-Ann S and Happel, Anna-Ursula and Kwon, Douglas S and Symul, Laura and Potloane, Disebo and Ngcapu, Sinaye and Mitchell, Caroline M},
  title = {Geographic Variation in Diagnostic Performance of Amsel Criteria and Nugent Score for Vaginal Dysbiosis Defined by 16S rRNA Gene Sequencing},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag399}
}
Kostenlos starten →